Development of a validated Western blot method for quantification of human dystrophin protein used in phase 2 and 3 clinical trials of eteplirsen for the treatment of Duchenne muscular dystrophy
Titel:
Development of a validated Western blot method for quantification of human dystrophin protein used in phase 2 and 3 clinical trials of eteplirsen for the treatment of Duchenne muscular dystrophy
Auteur:
Schnell, F.J. Donoghue, C. Dworzak, J. Charleston, J. Frank, D. Wilton, S. Fletcher, S. Lewis, S. Mendell, J.R. Rodino-Klapac, L.R. Sahenk, Z.